USA: 
Europe: 
Email: 
Consultation
| Catalog: | C1308T |
| Product Type: | Test kit |
| Unit: | 96 tests |
| Tested parameter: | amyloid beta |
| Sample type: | cerebrospinal fluid |
| Test type: | quantitative |
| Analysis mode: | enzyme immunoassay |
| Application: | neurodegenerative diseases |
The test uses solid-phase enzyme immunoassay method for the quantitative determination of β-amyloid(1-40) in human cerebrospinal fluid (CSF)1,2 in the clinical setting of dementia diagnosis. Values for the 40- and 42-AA-long β-amyloid peptides can be expressed as a β-amyloid ratio, which is of particular use in patients in which an indeterminate CSF biomarker profile (based on 42-AA-long β-amyloid, TAU and Phospho-TAU) is observed1,2.
Diagnostic Development
Follow Us -
Copyright © 2024 Creative Bioarray. All rights reserved.
